Clinical trial
Malignant Ascites in Ovarian Cancer: Impact of Total Paracentesis on Hemodynamics
NCT04032600 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Malignant Ascites in Ovarian Cancer: Impact of Total Paracentesis on Hemodynamics
- Lead sponsor
- Charite University, Berlin, Germany
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- August 1, 2017
- Completion date
- September 9, 2019
- Enrollment
- 61 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hemodynamic instability, malignant ascites, ovarian cancer